No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
FSM240517P5500
- 0.45
- +0.11+32.35%
15min DelayClose May 13 16:00 ET
0.45High0.45Low
0.45Open0.34Pre Close1 Volume43 Open Interest5.50Strike Price45.00Turnover72.84%IV-0.59%PremiumMay 17, 2024Expiry Date0.42Intrinsic Value100Multiplier4DDays to Expiry0.03Time Value100Contract SizeAmericanOptions Type-0.8374Delta0.6320Gamma11.29Leverage Ratio-0.0110Theta-0.0004Rho-9.45Eff Leverage0.0013Vega
Intraday
- 5D
- 1D
News
Fortuna Silver (NYSE:FSM): Undervalued Despite Surging Demand for Precious Metals
Fortuna Silver Mines Inc Price Target Raised to C$8.00/Share From C$6.50 by BMO Capital Markets
Fortuna Silver Mines Inc Price Target Raised to C$8.00/Share From C$6.50 by BMO Capital Markets
Fortuna Silver Mines Inc. (NYSE:FSM) Q1 2024 Earnings Call Transcript
Fortuna Silver Mines First Quarter 2024 Earnings: EPS: US$0.086 (Vs US$0.037 in 1Q 2023)
Express News | NYSE Order Imbalance 51955.0 Shares on Sell Side
Fortuna Silver Mines' Profits Surge in Q1
Comments
1
$Fortuna Silver Mines(FSM.US$ I made my entry into this one today,think good longterm invrstment
2
Gapping up
Select biotech/pharma names showing strength following ESMO:
$Clovis Oncology(CLVS.US$ +11.3%, $Cardiff Oncology(CRDF.US$ +9%, $Immatics(IMTX.US$ +8.3%, $IDEAYA Biosciences(IDYA.US$ +8%, $Lyra Therapeutics(LYRA.US$ +5.7%, $POINT Biopharma(PNT.US$ +5.7%, $Edgewise Therapeutics(EWTX.US$ +4.7%, $Concert Pharmaceuticals(CNCE.US$ +3.6%, $Deciphera Pharmaceuticals(DCPH.US$ +3.2%, $Veracyte(VCYT.US$ +2.6%, $SpringWorks Therapeutics(SWTX.US$ +2.3%,...
Select biotech/pharma names showing strength following ESMO:
$Clovis Oncology(CLVS.US$ +11.3%, $Cardiff Oncology(CRDF.US$ +9%, $Immatics(IMTX.US$ +8.3%, $IDEAYA Biosciences(IDYA.US$ +8%, $Lyra Therapeutics(LYRA.US$ +5.7%, $POINT Biopharma(PNT.US$ +5.7%, $Edgewise Therapeutics(EWTX.US$ +4.7%, $Concert Pharmaceuticals(CNCE.US$ +3.6%, $Deciphera Pharmaceuticals(DCPH.US$ +3.2%, $Veracyte(VCYT.US$ +2.6%, $SpringWorks Therapeutics(SWTX.US$ +2.3%,...
10
Read more